180 related articles for article (PubMed ID: 21983837)
21. PET study on mice bearing human colon adenocarcinoma cells using [11C]GF120918, a dual radioligand for P-glycoprotein and breast cancer resistance protein.
Yamasaki T; Kawamura K; Hatori A; Yui J; Yanamoto K; Yoshida Y; Ogawa M; Nengaki N; Wakisaka H; Fukumura T; Zhang MR
Nucl Med Commun; 2010 Nov; 31(11):985-93. PubMed ID: 20859232
[TBL] [Abstract][Full Text] [Related]
22. The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors.
Patel KJ; Tannock IF
BMC Cancer; 2009 Oct; 9():356. PubMed ID: 19807929
[TBL] [Abstract][Full Text] [Related]
23. Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice.
Hubensack M; Müller C; Höcherl P; Fellner S; Spruss T; Bernhardt G; Buschauer A
J Cancer Res Clin Oncol; 2008 May; 134(5):597-607. PubMed ID: 17932689
[TBL] [Abstract][Full Text] [Related]
24. A Prediction Method for P-glycoprotein-Mediated Drug-Drug Interactions at the Human Blood-Brain Barrier From Blood Concentration-Time Profiles, Validated With PET Data.
Matsuda A; Karch R; Bauer M; Traxl A; Zeitlinger M; Langer O
J Pharm Sci; 2017 Sep; 106(9):2780-2786. PubMed ID: 28385544
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein imaging in temporal lobe epilepsy: in vivo PET experiments with the Pgp substrate [11C]-verapamil.
Feldmann M; Koepp M
Epilepsia; 2012 Nov; 53 Suppl 6():60-3. PubMed ID: 23134497
[TBL] [Abstract][Full Text] [Related]
26. Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain Barrier.
Bauer M; Römermann K; Karch R; Wulkersdorfer B; Stanek J; Philippe C; Maier-Salamon A; Haslacher H; Jungbauer C; Wadsak W; Jäger W; Löscher W; Hacker M; Zeitlinger M; Langer O
Clin Pharmacol Ther; 2016 Aug; 100(2):131-41. PubMed ID: 26940368
[TBL] [Abstract][Full Text] [Related]
27. Visualization of multidrug resistance in vivo.
Hendrikse NH; Franssen EJ; van der Graaf WT; Vaalburg W; de Vries EG
Eur J Nucl Med; 1999 Mar; 26(3):283-93. PubMed ID: 10079321
[TBL] [Abstract][Full Text] [Related]
28. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.
Seebacher NA; Richardson DR; Jansson PJ
Cell Death Dis; 2016 Dec; 7(12):e2510. PubMed ID: 27906178
[TBL] [Abstract][Full Text] [Related]
29. A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier.
Wanek T; Kuntner C; Bankstahl JP; Mairinger S; Bankstahl M; Stanek J; Sauberer M; Filip T; Erker T; Müller M; Löscher W; Langer O
J Cereb Blood Flow Metab; 2012 Nov; 32(11):2002-11. PubMed ID: 22828996
[TBL] [Abstract][Full Text] [Related]
30. (R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.
Syvänen S; Luurtsema G; Molthoff CF; Windhorst AD; Huisman MC; Lammertsma AA; Voskuyl RA; de Lange EC
BMC Med Imaging; 2011 Jan; 11():1. PubMed ID: 21199574
[TBL] [Abstract][Full Text] [Related]
31. Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.
Kreisl WC; Bhatia R; Morse CL; Woock AE; Zoghbi SS; Shetty HU; Pike VW; Innis RB
J Nucl Med; 2015 Jan; 56(1):82-7. PubMed ID: 25500831
[TBL] [Abstract][Full Text] [Related]
32. Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.
Pajeva IK; Sterz K; Christlieb M; Steggemann K; Marighetti F; Wiese M
ChemMedChem; 2013 Oct; 8(10):1701-13. PubMed ID: 23943604
[TBL] [Abstract][Full Text] [Related]
33. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, and radiosynthesis of fluorine-18-AVT-011 as a Pgp chemoresistance imaging marker.
Kumar P; Thakur R; Acharya PC; Mohan HK; Pallavi UN; Maheshwari D; Mohammed K M A; Kumar A; Goud Nerella S; Joshi RK; Kumar M; Nagaraj C
Sci Rep; 2022 Nov; 12(1):18584. PubMed ID: 36329151
[TBL] [Abstract][Full Text] [Related]
35. A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.
Kelly RJ; Robey RW; Chen CC; Draper D; Luchenko V; Barnett D; Oldham RK; Caluag Z; Frye AR; Steinberg SM; Fojo T; Bates SE
Oncologist; 2012; 17(4):512. PubMed ID: 22416063
[TBL] [Abstract][Full Text] [Related]
36. Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study.
Bauer M; Karch R; Zeitlinger M; Philippe C; Römermann K; Stanek J; Maier-Salamon A; Wadsak W; Jäger W; Hacker M; Müller M; Langer O
J Cereb Blood Flow Metab; 2015 May; 35(5):743-6. PubMed ID: 25669913
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography.
Müllauer J; Kuntner C; Bauer M; Bankstahl JP; Müller M; Voskuyl RA; Langer O; Syvänen S
EJNMMI Res; 2012 Oct; 2(1):58. PubMed ID: 23072492
[TBL] [Abstract][Full Text] [Related]
38. The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study.
Mairinger S; Bankstahl JP; Kuntner C; Römermann K; Bankstahl M; Wanek T; Stanek J; Löscher W; Müller M; Erker T; Langer O
Epilepsy Res; 2012 Jun; 100(1-2):93-103. PubMed ID: 22342565
[TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein overactivity in epileptogenic developmental lesions measured in vivo using (R)-[
Ilyas-Feldmann M; Asselin MC; Wang S; McMahon A; Anton-Rodriguez J; Brown G; Hinz R; Duncan JS; Sisodiya SM; Koepp M
Epilepsia; 2020 Jul; 61(7):1472-1480. PubMed ID: 32627849
[TBL] [Abstract][Full Text] [Related]
40. Liposomes Coloaded with Elacridar and Tariquidar To Modulate the P-Glycoprotein at the Blood-Brain Barrier.
Nieto Montesinos R; Béduneau A; Lamprecht A; Pellequer Y
Mol Pharm; 2015 Nov; 12(11):3829-38. PubMed ID: 26390138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
